Sarepta Therapeutics

News and Video Search Results

News coverage

Global Antisense and RNAi Therapeutics Report 2024: A USD 34.7 Billion Predicted Market by 2034, with CAGR of 18% During 2024-2034

GlobeNewswire 16 Apr 2024

Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Global Antisense and RNAi Therapeutics Market" report has been added to *..

Notice of Annual General Meeting in Karolinska Development AB (publ)
GlobeNewswire 16 Apr 2024
Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy
SeekingAlpha 11 Apr 2024
Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts
SeekingAlpha 08 Apr 2024
United States: REGENXBIO And Sarepta Agree To Stay Litigation Pending Outcome Of Sarepta's IPR Petition - Goodwin Procter LLP
Mondaq 04 Apr 2024

0 shares 1 views

You might like

Sarepta Therapeutics media coverage

Global Regenerative Medicine Industry Research 2023-2028: Market Driven by Wide Scope in New Therapeutic Areas and Collaborations and Partnerships

Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic],..

GlobeNewswire 03 Apr 2024